In contrast, PRDX1-related pathways, including vascular-associated smooth muscle cell differentiation, smooth muscle cell differentiation, IL-6 mediated signaling pathway, endosome to plasma membrane protein transport, gene silencing by RNA, and negative regulation of transporter activity, were suppressed in HCC patients. This evidence concerns the gene PRDX1 and hepatocellular carcinoma.